Trial Profile
Revatio Special Investigation - Investigation for Long-Term Use of Revatio in Pediatric Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2022
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Viatris Inc
- 29 Sep 2022 Status changed from active, no longer recruiting to completed.
- 23 Mar 2022 Planned End Date changed from 28 Mar 2022 to 31 May 2022.
- 23 Mar 2022 Planned primary completion date changed from 28 Mar 2022 to 31 May 2022.